Skip to main content
[Preprint]. 2021 Sep 28:2021.09.18.21263605. [Version 1] doi: 10.1101/2021.09.18.21263605

Figure 2.

Figure 2.

Samples collected from volunteer subjects (n=99) at different time intervals for Pfizer (n=47) and Moderna (n=52) vaccines were tested and binned to different time intervals relative to completion of second dose of mRNA vaccine.